BERKELEY HEIGHTS, N.J., Jan. 6, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that the Company will present at the Biotech ShowcaseTM 2014 conference being held at Parc 55 Wyndham San Francisco – Union Square at 55 Cyril Magnin Street, San Francisco, Calif. Spiro Rombotis, President and Chief Executive Officer, will provide an overview of the Company and its progress in key programs at 9:30 a.m. PST on Monday, January 13, 2014.
Help employers find you! Check out all the jobs and post your resume.
